Interferon (IFN) therapy for certain cancer types has proven successful, however resistance often develops. The RST2 cell line was developed to study IFN resistance. This line was isolated from the highly IFN-sensitive Daudi cell line by growth in the continuous presence of IFN.
RST2 cell line characteristics:
From the laboratory of Lawrence Pfeffer, PhD, University of Tennessee.
Part of The Investigator's Annexe program.
Product Type: | Cell Line |
Name: | Daudi |
Cell Type: | STAT2-defective mutant of Daudi cells |
Accession ID: | P52630, CVCL_5I55 |
Organism: | Homo sapien |
Biosafety Level: | BSL-2 |
Subculturing: | 1:4 twice a week, maitain 1 and 10X105 cells/mL |
Growth Conditions: | RPMI1640 and 10% defined calf serum |
Cryopreservation: | RPMI1640 + 20%FCS + 10% dimethyl sulfoxide |
Storage: | Liquid nitrogen |
Shipped: | Dry ice |
IFN induced antiviral activities in Daudi and RST2 cells1:
Daudi and RST2 cells were treated overnight with the indicated concentrations of IFNa. The cells were then infected with VSV at 0.1 plaque-forming unit/cell, and the virus yield in the medium was determined by plaque formation.
If you publish research with this product, please let us know so we can cite your paper.